Synerga.Fund

SNG · WAR · Technology / Software - Application

0.385PLN-0.01 (-1.28%)

Price History

Full chart

Market Stats

Previous Close0.39

Open0.385

Day Range0.385 – 0.385

52-Week Range0.26 – 0.878

Volume1.85K

Market Cap65.00M

P/E (TTM)0.00

Forward P/E0.00

EPS0.1609

Dividend Yield0.00%

50-Day Avg0.00

200-Day Avg0.00

About

Synerga.Fund S.A. engages in the stem cell therapy business for multiple sclerosis in Poland. It focuses on the implementation of medical project in the field of biotechnology and advanced cell therapies. The company was founded in 2010 and is based in Kraków, Poland.

Company Details

SectorTechnology
IndustrySoftware - Application
CEOMr. Tomasz Wykurz
Headquartersul. Cystersów 21C/130, Kraków, Poland, 31-553, Poland
Websitehttps://www.SYNERGAfund.com.pl

Leadership

Mr. Tomasz WykurzChairman of the Management Board

Financials

Income Statement

Currency: PLN	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	35.20K	25.36K	17.00K	-	100.00K	49.76K	170.00K	35.24K	0	15.00K
Growth (%)	-	-27.95%	-32.97%	-	-	-50.24%	+241.67%	-79.27%	-100.00%	-
Cost of Revenue	200	550	310	20	122.26K	23.89K	35.46K	13.50K	15.96K	14.73K
Gross Profit	35.00K	24.81K	16.69K	-20	100.00K	25.86K	134.54K	21.74K	-15.96K	270.36
Gross Margin	99.43%	97.83%	98.18%	-	100.00%	51.98%	79.14%	61.69%	-	1.80%
Operating Expense	176.98K	154.96K	127.30K	138.11K	227.56K	184.98K	366.50K	137.10K	114.73K	108.96K
Operating Income	-141.98K	-130.15K	-110.61K	-138.13K	-127.56K	-159.12K	-231.96K	-115.36K	-130.69K	-108.69K
Operating Margin	-403.35%	-513.21%	-650.65%	-	-127.56%	-319.79%	-136.44%	-327.31%	-	-724.62%
EBITDA	-	-	-	-	-	-	-4.20M	-31.33K	-1.18M	-1.31M
EBITDA Margin	-	-	-	-	-	-	-2472.88%	-88.88%	-	-8707.66%
Net Income	-2.96M	-143.41K	-138.41K	-191.42K	26.35M	-20.18M	-3.34M	-76.32K	-1.06M	-1.13M
Net Income Margin	-8418.72%	-565.50%	-814.18%	-	26345.58%	-40566.96%	-1964.11%	-216.54%	-	-7518.50%
Interest Expense	0	0	0	0	85.88K	86.80K	24.42K	71.01K	73.97K	29.57K
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	-	85.88%	174.45%	14.36%	201.47%	-	197.13%

Balance Sheet

Currency: PLN	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	219.88K	23.41K	81.77K	988.41K	33.97M	7.51M	3.47M	3.38M	2.32M	30.86K
Total Liabilities	337.72K	284.65K	495.33K	1.59M	8.23M	1.96M	1.25M	1.24M	1.23M	74.63K
Total Equity	-117.83K	-261.24K	-413.56K	-604.97K	25.74M	5.56M	2.22M	2.14M	1.08M	-43.77K
Cash	-	-	-	-	19.99K	111.44K	6.46K	31.03K	36.11	0
Net Debt	-	-	-	612.17K	1.83M	-	617.86K	703.98K	893.95K	13.18K

Cash Flow

Currency: PLN	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-758.13K	-141.59K	-286.53K	-84.55K	-1.14M	-144.34K	-704.98K	-15.43K	-115.99K	-140.07K
Investing Cash Flow	-32.72K	-	-6.88K	-	-	-	-	-	-	-
Financing Cash Flow	33.73K	123.50K	289.71K	85.00K	1.15M	-	-	-	-	-
Capital Expenditure	0	0	6.88K	0	0	0	0	0	0	0
Free Cash Flow	-	-	-	-	-1.14M	-144.34K	-704.98K	-15.43K	-115.99K	-140.07K
FCF to OCF	-	-	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%

Key Statistics & Ratios

Market Cap65.00M

Enterprise Value0

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.00

Price / Book0.00

EPS0.1609

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity20491.00%

Return on Assets0.00%

Shares Outstanding0

Shares Float0

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Apr 1, 20221:10